/ACUS
ACUS Stock - Acusphere, Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ACUS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.36
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2007 | FY2006 | FY2005 | FY2004 | FY2003 |
|---|---|---|---|---|---|
| Revenue | $2.67M | $1.78M | $3.43M | $1.71M | N/A |
| Gross Profit | $2.67M | $1.78M | $3.43M | $1.71M | N/A |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | N/A |
| Operating Income | $52.73M | $62.28M | $46.18M | $30.43M | $19.71M |
| Net Income | $-53,730,000 | $-61,089,000 | $-44,625,375 | $-29,959,048 | $-21,923,437 |
| Net Margin | -2014.6% | -3430.0% | -1301.6% | -1747.6% | N/A |
| EPS | $-12.60 | $-22.13 | $-23.61 | $-19.20 | $-52.35 |
Company Overview
Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ACUSBeat Rate
30%
Last 20 quarters
Avg Surprise
-16.5%
EPS vs Estimate
Beats / Misses
6/13
1 met exactly
Latest EPS
$-6.70
Q1 2009
EPS Surprise History
Q2 07
-8.6%
$-3.40vs$-3.13
Q3 07
-18.7%
$-3.80vs$-3.20
Q4 07
-12.3%
$-3.20vs$-2.85
Q1 08
+6.9%
$-2.70vs$-2.90
Q2 08
-25.0%
$-3.00vs$-2.40
Q3 08
0.0%
$-2.50vs$-2.50
Q4 08
-15.0%
$-2.30vs$-2.00
Q1 09
-219.0%
$-6.70vs$-2.10
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2009 | Mar 31, 2009 | $-2.10 | $-6.70 | -219.0% | ✗ MISS |
Q4 2008 | Nov 10, 2008 | $-2.00 | $-2.30 | -15.0% | ✗ MISS |
Q3 2008 | Aug 11, 2008 | $-2.50 | $-2.50 | 0.0% | = MET |
Q2 2008 | May 8, 2008 | $-2.40 | $-3.00 | -25.0% | ✗ MISS |
Q1 2008 | Mar 17, 2008 | $-2.90 | $-2.70 | +6.9% | ✓ BEAT |
Q4 2007 | Nov 8, 2007 | $-2.85 | $-3.20 | -12.3% | ✗ MISS |
Q3 2007 | Aug 8, 2007 | $-3.20 | $-3.80 | -18.7% | ✗ MISS |
Q2 2007 | May 10, 2007 | $-3.13 | $-3.40 | -8.6% | ✗ MISS |
Q1 2007 | Mar 19, 2007 | $-3.76 | $-3.90 | -3.7% | ✗ MISS |
Q4 2006 | Nov 14, 2006 | $-4.18 | $-4.60 | -10.0% | ✗ MISS |
Q3 2006 | Aug 9, 2006 | $-4.67 | $-8.40 | -79.9% | ✗ MISS |
Q2 2006 | May 12, 2006 | $-5.70 | $-6.10 | -7.0% | ✗ MISS |
Q1 2006 | Mar 20, 2006 | $-5.27 | $-5.60 | -6.3% | ✗ MISS |
Q4 2005 | Nov 10, 2005 | $-5.77 | $-5.80 | -0.5% | ✗ MISS |
Q3 2005 | Aug 15, 2005 | $-8.50 | $-9.20 | -8.2% | ✗ MISS |
Q2 2005 | May 12, 2005 | $-4.95 | $-4.50 | +9.1% | ✓ BEAT |
Q1 2005 | Mar 15, 2005 | $-5.85 | $-5.10 | +12.8% | ✓ BEAT |
Q4 2004 | Nov 12, 2004 | $-6.05 | $-3.90 | +35.5% | ✓ BEAT |
Q3 2004 | Aug 5, 2004 | $-5.60 | $-5.30 | +5.4% | ✓ BEAT |
Q2 2004 | May 6, 2004 | $-5.60 | $-4.80 | +14.3% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about ACUS
What is ACUS's current stock price?
Acusphere, Inc. (ACUS) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for ACUS?
No analyst price targets are currently available for this stock.
What sector is Acusphere, Inc. in?
Acusphere, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is ACUS's market cap?
Acusphere, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does ACUS pay dividends?
No, Acusphere, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAQSZF
Aequus Pharmaceuticals Inc.
$0.00
Mkt Cap: $0.0B
BBBT
Black Bird Biotech, Inc.
$0.00
Mkt Cap: $0.0B
DVLP
Golden Developing Solutions, Inc.
$0.00
Mkt Cap: $0.0B
IRBS
IR Biosciences Holdings Inc.
$0.00
Mkt Cap: $0.0B
MCIC
MultiCorp International, Inc.
$0.00
Mkt Cap: $0.0B
NEPTF
Neptune Wellness Solutions Inc.
$0.00
Mkt Cap: $0.0B
NXEN
Nexien BioPharma, Inc.
$0.00
Mkt Cap: $0.0B
RMRK
Rimrock Gold Corp.
$0.00
Mkt Cap: $0.0B
TOMDF
Todos Medical Ltd.
$0.00
Mkt Cap: $0.0B
XTXXF
Adastra Holdings Ltd.
$0.02
Mkt Cap: $0.0B
Explore stocks similar to ACUS for comparison